The Effect of Reduced Liver Function on Selatogrel Pharmacokinetics

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 22, 2020

Primary Completion Date

October 23, 2020

Study Completion Date

October 23, 2020

Conditions

Healthy SubjectsHepatic Impairment

Interventions

DRUG

Selatogrel

A single subcutaneous injection of 16 mg.

Trial Locations (1)

CRS Clinical Research Services, Kiel

All Listed Sponsors

lead

Viatris Innovation GmbH

INDUSTRY

NCT04406896 - The Effect of Reduced Liver Function on Selatogrel Pharmacokinetics | Biotech Hunter | Biotech Hunter